Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/11/2012CN102573854A 5'-methylthioadenosine neuroprotective properties
07/11/2012CN102573853A Method of reducing multi-drug resistance using inositol tripyrophosphate
07/11/2012CN102573852A Pharmaceutical compositions for treating IBD
07/11/2012CN102573851A Broad spectrum preservation blends
07/11/2012CN102573850A Screening method and therapy with agonists of DDAH I
07/11/2012CN102573849A Medicinal composition for iontophoresis
07/11/2012CN102573848A Composition for preventing and treating alopecia disorder containing norgalanthamine compounds as an active ingredient
07/11/2012CN102573847A Methods and compositions for treating degenerative and ischemic disorders
07/11/2012CN102573846A Heterocyclic compounds and uses thereof
07/11/2012CN102573845A Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
07/11/2012CN102573844A Treatment of heart failure with normal ejection fraction
07/11/2012CN102573843A Transdermally absorbable donepezil-containing preparation
07/11/2012CN102573842A Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives
07/11/2012CN102573841A Method of treating age related disorders
07/11/2012CN102573840A Pharmaceutical compositions
07/11/2012CN102573839A Method of decreasing ubiquitylated protein levels
07/11/2012CN102573838A Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
07/11/2012CN102573837A Methods of treating neuropathic pain with benzimidazole derivative agonists of PPARgamma
07/11/2012CN102573836A Use of substituted oxindole derivatives for the treatment and prophylaxis of pain
07/11/2012CN102573835A Film-coated tablet which is suppressed in discoloration and odor
07/11/2012CN102573834A Combination of proantocycidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis
07/11/2012CN102573833A Cancer cell apoptosis
07/11/2012CN102573832A Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
07/11/2012CN102573831A Desferrioxamine-metal complexes for the treatment of immune-related disorders
07/11/2012CN102573830A Use of nicotinic acetylcholine receptor alpha 7 activators
07/11/2012CN102573829A Composition comprising S-allyl-L-cysteine as active ingredient for preventing or treating gastrointestinal disorders
07/11/2012CN102573828A Cell protection in dialysis patients by administration of a creatine compound
07/11/2012CN102573827A Pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseases
07/11/2012CN102573826A Pentamidine combinations for treating cancer
07/11/2012CN102573825A Co-crystals of tramadol and coxibs
07/11/2012CN102573824A Compositions comprising tramadol and celecoxib in the treatment of pain
07/11/2012CN102573823A Compositions comprising transnorsertraline and serotonin receptor 1a agonists/ antagonists and uses thereof
07/11/2012CN102573822A Stress-alleviating agent comprising plant-derived polyamine-containing extract as active ingredient
07/11/2012CN102573821A Smoking cessation with body weight maintenance and nutritional supplement
07/11/2012CN102573820A Compositions comprising an anti-inflammatory blend
07/11/2012CN102573819A Heparanase-activity inhibitor, wrinkle ameliorating agent containing same, and pharmaceutical composition
07/11/2012CN102573815A Treatment and prevention of HIV infection
07/11/2012CN102573814A Polymer vesicles of asymmetric membrane
07/11/2012CN102573809A Crystallization method and bioavailability
07/11/2012CN102573808A Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
07/11/2012CN102573807A Ferric citrate dosage forms
07/11/2012CN102573806A Tamper-resistant dosage form for oxidation-sensitive opioids
07/11/2012CN102573805A Hot-melt extruded controlled release dosage form
07/11/2012CN102573804A Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
07/11/2012CN102573803A Solid dispersion comprising an anti-HIV agent
07/11/2012CN102573800A Ophthalmic drug delivery system containing phospholipid and cholesterol
07/11/2012CN102573799A Pharmaceutical composition containing medicament-containing fine particles and method for producing same
07/11/2012CN102573795A Liquid pharmaceutical compositions
07/11/2012CN102573794A Cysteine for physiological injection
07/11/2012CN102573791A Improved formulations
07/11/2012CN102573770A Isopropyl methyl phenol-containing liquid composition for oral cavity
07/11/2012CN102573765A Topical compositions containing coated active agents
07/11/2012CN102573524A Regulating the amino acid pool used for the acute-phase protein synthesis
07/11/2012CN102573518A A xylitol containing comestible product
07/11/2012CN102573517A Stable thickener formulations
07/11/2012CN102573503A Flavanones-containing food compositions
07/11/2012CN102573496A Slow release magnesium composition and uses thereof
07/11/2012CN102573493A 2-substituted-ethynylthiazole derivatives and uses of same
07/11/2012CN102573489A Methods for iontophoretically treating nausea and migraine
07/11/2012CN102573487A Pyridil-triazine inhibitors of hedgehog signaling
07/11/2012CN102573486A Triazine derivatives and their therapeutical applications
07/11/2012CN102573485A Triazine derivatives and their therapeutical applications
07/11/2012CN102573484A Benzyl substituted triazine derivatives and their therapeutical applications
07/11/2012CN102573483A Triazine derivatives and their therapeutical applications
07/11/2012CN102573482A Styryl-triazine derivatives and their therapeutical applications
07/11/2012CN102573481A Ureidophenyl substituted triazine derivatives and their therapeutical applications
07/11/2012CN102573480A Triazine derivatives and their therapeutical applications
07/11/2012CN102573477A Treatment method
07/11/2012CN102573475A Intravenous formulations of neurokinin-1 antagonists
07/11/2012CN102573473A Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of HEDGEHOG signaling
07/11/2012CN102573472A Method for treating androgen receptor positive cancers
07/11/2012CN102573470A ITE for cancer intervention and eradication
07/11/2012CN102573469A Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof
07/11/2012CN102573466A Use of guanethidine for treating hypertension by local vascular delivery
07/11/2012CN102573463A N-acetyl cysteine compositions and methods to improved the therapeutic efficacy of acetaminophen
07/11/2012CN102573462A 3-substituted compounds for reducing uric acid
07/11/2012CN102559828A Method for preparing astragaloside IV by converting total saponins of astragalus by microorganisms
07/11/2012CN102558535A Amphiphilic block copolymer connected through molecular glue and synthesis method and application of copolymer
07/11/2012CN102558530A Selenium-containing curcumin polymer and its preparation method and application
07/11/2012CN102558393A Preparation process of dalteparin sodium
07/11/2012CN102558391A Vitamin E succinate-chitosan graft and preparation method and application thereof
07/11/2012CN102558389A Low molecular weight carboxyl-reduced derivatives of fucosylated glycosaminoglycans and preparation method and applications of low molecular weight carboxyl-reduced derivatives
07/11/2012CN102558383A Bismuth alginate and preparation method and application thereof
07/11/2012CN102558288A Preparation method of jolkinolide compound and application thereof
07/11/2012CN102558287A Dehydro-tanshinone IIA sulfoacid and application thereof
07/11/2012CN102558278A Triterpene compound and application thereof in preparation of anti-complementary medicament
07/11/2012CN102558277A Synthesis method of titerpene saponin compound stryphnoside A
07/11/2012CN102558276A Non-sizing pipecuronium and preparation method and purpose thereof
07/11/2012CN102558275A Alpha type polycrystalline abiraterone acetate crystal, and preparation method, application and pharmaceutical composition thereof
07/11/2012CN102558270A 20(S) and 20(R)-dammarane-3beta,12beta,20,25-tetrol derivative and preparation method and application thereof
07/11/2012CN102558263A Doxifluridine derivative and preparation method and pharmaceutical application thereof
07/11/2012CN102558261A Nucleotide analogue and synthesis and application thereof
07/11/2012CN102558258A Strictosidine lactam alkaloid and preparation method and application thereof
07/11/2012CN102558255A Aminoglycoside compound and extracting and separating method thereof
07/11/2012CN102558249A Salvia miltiorrhiza stachyose, and preparation method and application thereof
07/11/2012CN102558235A Method for preparing arsanilic acid by diazotizing trimethoprim
07/11/2012CN102558234A Method for preparing arsanilic acid preparation by diazotization of amino phenylarsonic acid
07/11/2012CN102558231A Ophthalmic compositions for treating ocular hypertension
07/11/2012CN102558224A Phosphorus propofol sodium hydrate and preparation method and purpose thereof
07/11/2012CN102558222A Resveratrol germanium sesquioxide compound, preparation method thereof and application thereof
1 ... 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 ... 7860